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Abstract
Pregnant women become susceptible to malaria infection despite their acquired immunity to this disease from childhood.
The placental sequestration of Plasmodium falciparum infected erythrocytes (IE) is the major feature of malaria during
pregnancy, due to ability of these parasites to bind chondroitin sulfate A (CSA) in the placenta through the VAR2CSA
protein that parasites express on the surface of IE. We collected parasites at different times of pregnancy and investigated
the adhesion pattern of freshly collected isolates on the three well described host receptors (CSPG, CD36 and ICAM-1). Var
genes transcription profile and VAR2CSA surface-expression were assessed in these isolates. Although adhesion of IE to
CD36 and ICAM-1 was observed in some isolates, CSA-adhesion was the predominant binding feature in all isolates
analyzed. Co-existence in the peripheral blood of several adhesion phenotypes in early pregnancy isolates was observed, a
diversity that gradually tightens with gestational age in favour of the CSA-adhesion phenotype. Infections occurring in
primigravidae were often by parasites that adhered more to CSA than those from multigravidae. Data from this study
further emphasize the specificity of CSA adhesion and VAR2CSA expression by parasites responsible for pregnancy malaria,
while drawing attention to the phenotypic complexity of infections occurring early in pregnancy as well as in multigravidae.
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Introduction
Despite the substantial protective anti-malarial immunity
gradually acquired during childhood in residents of areas with
high malaria transmission, during their first pregnancy women are
more at risk of infection by Plasmodium falciparum compared to non-
pregnant adults [1]. The sequestration of P. falciparum-infected
erythrocytes (IE) in the placenta is the key characteristic of
pregnancy-associated malaria (PAM), and can be associated with
intense inflammatory activity. The latter is more common in
women during their first pregnancy. The pregnancy-specific aspect
has been attributed to parasites expressing particular variant
surface antigens [2,3]. Severe maternal anemia and delivery of
babies with low birth weight are the major consequences
associated with the accumulation of IE in the placenta [4]. The
best-characterized adhesion ligands expressed on the surface of IE
are members of the highly polymorphic Plasmodium falciparum
erythrocyte membrane protein-1 (PfEMP-1) family, encoded by
the var gene family [5]. Var genes can be classified into 5 majors
groups (A to E) based on the sequence polymorphism observed
both in the non-coding upstream region and also in the coding
sequence [2,6–8]. A particular PfEMP1, named VAR2CSA, is
now recognized as the main parasite ligand mediating IE binding
to placental tissue [2,9,10].
Numerous characteristics of VAR2CSA make it the major
candidate for development of a vaccine to prevent PAM,
characteristics that have been described in multiple studies
[2,9,11–19]. However, data concerning the adhesion patterns of
parasite isolates collected throughout pregnancy, and the kind of
interactions that can characterize isolates present at different times
of pregnancy, remain fully to be generated. Although it has been
suggested that other molecules (hyaluronic acid and non-immune
globulins) may participate in the adhesion of IE in the placenta
[20–22], several lines of evidence indicate that CSA is the most
important receptor involved [2,3,17,23–28]. Endothelial recep-
tors, such as CD36 and ICAM-1, commonly support the adhesion
of field isolates [26] from non-pregnant patients [29–31].
However, it has been shown that these two receptors are highly
expressed in the placenta and ICAM-1 has been localized on
syncytiotrophoblasts, suggesting a possible role in the placental
sequestration of IE [32]. Other studies have nevertheless reported
that placental isolates do not bind to CD36 [20,22] and ICAM-1
PLOS ONE | www.plosone.org 1 June 2014 | Volume 9 | Issue 6 | e98577
[25]. Thus, the function and the level of involvement of these
molecules in the binding ability of IE collected from cases of PAM
are still not well explored. In this study, we sought to characterize
the binding properties ex vivo of field isolates collected from
pregnant women at different time-points of pregnancy using three
receptors expressed in the placenta that are known to support IE
binding (CSPG, CD36 and ICAM-1). In addition, we investigated
whether other pregnancy-related factors influence the parasite
adhesion properties and whether infection by parasites with a
particular adhesion pattern could be associated with poor
pregnancy outcomes.
Material and Methods
Study design, collection and handling of blood samples
Written informed consent was given by all women participating
in this study. The study was approved by the ethics committee of
the Faculty of Health Science (University of Abomey-Calavi) in
Benin. The study was conducted at the Suru Le´re´ maternity clinic,
Cotonou, Benin. All women were tested for P. falciparum infection
using a rapid diagnostic test (Parascreen, Zephyr Biomedicals Goa,
India), and those with a positive result were included. P. falciparum
IE were obtained from 123 pregnant women attending antenatal
visit and 9 women admitted for delivery. Venous blood was
collected in vacutainers with citrate phosphate dextrose adenine
anticoagulant. Thick and thin blood films were prepared from
blood samples to confirm P. falciparum infection. Hemoglobin
values of women and the birth weight of their offspring were
collected for all women included at delivery. Detailed character-
istics of the study site have been previously described [33].
Ring stage IE were allowed to mature in vitro to trophozoite-
stage, as described [34]. Briefly, isolates were grown in RPMI
1640 supplemented with Hepes and L-glutamine (Lonza Biowhit-
taker), 0.3 g/L l-glutamine, 0.05 g/L gentamicin, 5 g/L albumax.
Cultures were grown for no more than 48 h before testing. Ring
stage parasites were also conserved in 10 volumes of TRIzol
reagent (Invitrogen) and stored at 280uC until RNA extraction.
Flow cytometry and binding assays
VAR2CSA expression on the surface of P. falciparum IE was
assessed by flow cytometry using specific anti-VAR2CSA IgG as
previously described [35]. Briefly, 26105 late-stage IE enriched by
filtration on a magnetic column (VarioMACS, Miltenyi) were
labelled with ethidium bromide, and sequentially exposed to anti-
VAR2CSA rabbit IgG (final concentration 10 mg/ml), and to
FITC-conjugated anti-rabbit IgG (1.5 mg/ml, Invitrogen). The
anti-VAR2CSA rabbit IgG were purified from the plasma of
rabbits previously immunized with the extracellular full-length
protein from FCR3 strain [33]. A FACSCalibur flow-cytometer
(BD Biosciences) was used to acquire the data, and the median
fluorescence intensity (MFI) was determined. VAR2CSA surface
expression was considered positive with an MFI ratio (MFI with
IgG from rabbits immunized with VAR2CSA/MFI with IgG from
rabbits before immunization) .1.2, as previously described [35].
A static assay that measures the adhesion to purified,
immobilized receptors was used to assess the binding patterns of
isolates, as described [36]. Briefly, 5 mg/ml of CSPG-Decorin
(Sigma) or 10 mg/ml of ICAM-1 (R&D Systems) or CD36 (R&D
Systems) or bovine serum albumin (Sigma) were diluted in PBS,
and coated as spots in a 100615 mm Petri dish (Falcon 351029).
Late-stage IE enriched on a magnetic column (VarioMACS,
Miltenyi), with a parasite density adjusted to 20% in 16105 cells
were blocked in BSA/RPMI for 30 minutes at room temperature
(RT), and allowed to bind to coated receptors for 15 minutes at
RT. Unbound cells were removed by an automated washing
system. Bound IE were fixed with 1.5% glutaraldehyde in PBS,
stained with Giemsa, and quantified by microscopy, as the number
of IE bound per mm2. Each sample was performed in duplicate.
Based on the binding level of IE observed on BSA spots (data not
shown), a threshold of significant adhesion was determined as the
mean +3 standard deviations and was set as binding$35 IE/mm2.
RNA extraction, cDNA synthesis and quantification of var
gene transcripts
Thawed samples stored in TRIzol reagent were used to extract
the total RNA, as recommended by the manufacturer. The dried
pellet was resuspended with 10 ml of DEPC-water. RNA samples
were treated with DNase I (Invitrogen) for 30 min at RT. The
absence of gDNA in RNA samples was confirmed by no parasite
DNA amplification after 40 cycles of real-time PCR performed
with seryl-tRNA synthetase P. falciparum-specific primers, using a
Rotorgene 6000 thermal cycler system (Corbett Research).
Reverse transcription of DNA-free RNA was performed using
Thermoscript (Invitrogen) with random hexamer primers in a total
volume of 20 ml, as recommended by the manufacturer.
Var gene transcripts abundance was quantified by qPCR, as
described [36]. Briefly, runs were performed (95uC for 1 min,
followed by 40 cycles of 94uC for 30 s, 54uC for 40 s, and 68uC for
50 s) in a final volume of 20 ml, using 0.5 ml cDNA; 16SYBR
Green Mastermix (Bioline) and 1.25 mM of specific primer pairs
for individual gene or var gene subtypes. Primer pairs targeting the
conserved region of var2csa [9] and previously designed specific var-
type primers (A1, B1, B2, C1, C2, var1, and var3) were used, as
described [37]. Seryl-tRNA synthetase (primer pair p90) and fructose-
bisphosphate aldolase (primer pair p61) were used as endogenous
controls [2]. Non-template controls and the 3D7 gDNA, used as
calibrator, were performed for validation on every run. The
melting curve analysis was done to ensure the amplification
specificity. Samples with Cycle Threshold (CT) values exceeding
35 were not quantified. The relative copy number of var genes
transcripts was determined, as described [36].
Statistical analysis
Statistical analysis was performed using STATA software
version 11 (Stata corporation, College Station, Texas, United
States) and data were plotted using Prism software (version 5,
Graph-Pad). Transcripts with abundance values greater than 5%
of the total var genes analyzed were listed. Continuous variables
were compared by the Mann-Whitney and Kruskall-Wallis tests.
The Wilcoxon matched pairs test was used to compare matched
variables. A linear regression model was used to analyze the
binding level of parasites to each host receptor according to the
parity of women, the timing of pregnancy and surface expression
of VAR2CSA. The same analysis was performed on the data
defined as positive and negative binding to each receptor using a
logistic regression model. This latter model was performed, in
addition to linear model, to describe and predict the binding
pattern of isolates that infect women throughout pregnancy in
relation with the parity status of these women.
Results
Transcription profile of var genes by isolates collected
from pregnant women
Parasites were obtained from 132 pregnant women with a P.
falciparum infection, as confirmed by microscopical examination.
The clinical characteristics of these women are presented in
Table 1. Analysis of var genes transcripts diversity was performed
Adhesion Phenotype of Isolates from Pregnant Women
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on 100 cDNA successfully synthesized. Although transcripts of
several var genes were detected in most of the isolates, transcript of
var2csa was detected in 99 out of the 100 tested cDNA. Isolates
highly transcribed var2csa compared to other var genes (P,0.0001,
Figure 1). The median copy number of var2csa detected among
these isolates was 6.8 (IQR, 1.8–19.0) whereas other var genes
coverage by specific primers targeting A1, B1, B2, C1, C2, var1
and var3 showed a median copy number,0.2. Moreover, var1 was
exclusively transcribed by one isolate (OPT173), and transcripts of
var2csa were exclusively detected in eight isolates.
Adhesion phenotype of field isolates from pregnant
women
To limit changes in the structure of parasite populations in the
isolates studied, the culture time required in vitro to obtain mature
stages used in the binding phenotyping was limited to 48h. Isolates
with very low parasite density that required longer cultivation time
to yield sufficient IE were not retained for analyses. The ability of
parasites isolated from pregnant women to bind to host receptors
(CSPG, CD36, and ICAM-1) was assessed on 54 successfully-
matured isolates (50 samples collected during pregnancy and 4
samples obtained at delivery). Among these women, 13 were
primigravidae and 41 were multigravidae. The levels of binding to
each receptor (CSPG, CD36, and ICAM-1) are shown in Table 2.
Distinct binding ability was observed among the parasite isolates.
Although binding intensity also differed according to receptors,
most of the tested isolates showed adhesion to at least one of the
receptors (Table 2). Five isolates were not tested on CD36 and
ICAM-1 due to limited amounts of IE. However, significant
adhesion to CSPG was observed on 32 (59.2%) isolates, whereas
13 (26.5%) and 2 (4.1%) isolates showed substantial levels of
binding to CD36 and ICAM-1, respectively (Figure 2A). Overall,
isolates bound at significantly higher levels to CSPG (median =
81.5, 14.7–320.5) than to CD36 (8.0, 0–39.5) (P= 0.001) and to
ICAM-1 (0, 0.0–5.5) (P,0.0001). Furthermore, the binding
intensity to ICAM-1 was also lower than to CD36 (P= 0.0004),
suggesting that affinity to this receptor may of less importance to
isolates from pregnant women.
Relationship between VAR2CSA expression and the CSA-
binding phenotype
Var2csa is the only gene among the var genes examined in this
study that was detected in all of the 54 successfully-matured
isolates. To further refine the analysis we focus on the dominant
transcripts detected. Only var genes with transcript abundances
greater than 5% of the total var gene transcription [38], are
reported in Table 2 and the most prevalent transcript indicates the
dominant var gene of each isolate. Transcript abundance of var2csa
above the threshold (5%) was observed in 48 out of 54 isolates
whereas transcripts of var1 and group ABC var genes were
observed in 22/54 and in 25/54 (13/54 for var group A; 9/54 for
var group B and 17/54 for var group C) of isolates, respectively
(Table 2). Var2csa was exclusively or dominantly transcribed by 36
isolates. Var1 was dominantly transcribed by 10 isolates, while var
genes from groups ABC were dominantly transcribed by 6 isolates.
The distribution of the transcription levels of the three categories
of var genes (var1, var2csa and var ABC) was different in the two
groups of parasite phenotypes (Fisher Exact Test; P,0.0001).
Transcripts of var1 was the predominant transcript detected (46%)
among isolates with a CD36-binding phenotype (Table 3) while
var2csa was (87%) in isolates binding to CSPG.
Transcription data and that of VAR2CSA expression on the
surface of IE were further analyzed in relation to the adhesion
properties of the isolates (Table 4). Among the 32 isolates that
showed significant binding to CSPG, significant labeling of the IE
surface by anti-VAR2CSA antibodies was observed while only one
isolate (OPT091) was recognized among isolates which did not
show a CSPG binding phenotype (P= 0.005). Although all these
CSA-adhering isolates transcribed var2csa, only 28 (87.5%)
transcribed it as the dominant var. Among the 22 isolates which
did not significantly bind to CSPG, var2csa was dominantly
transcribed in 10 (45.4%), all of which were labeled by VAR2CSA
antibodies. In five isolates a positive surface labeling was observed
despite the fact var2csa was not the predominant transcript or just
hardly detected.
Adhesion phenotype of parasites is associated with
parity and gestational age of women
Isolates from primigravidae bound on average to a higher level
to CSPG than those from multigravidae (P= 0.05). Conversely,
Figure1. Var genes transcription profile of isolates collected
from pregnant women. Transcription level of var genes were shown
as relative copy number. Bars indicate the median of distribution.
doi:10.1371/journal.pone.0098577.g001
Table 1. Clinical characteristics of the women and their offspring birth weight.
N=132 Mean Median IQR
Parasitemia (/ml) 71,781 18,207 3,927–59,719
Age (years) 26.3 27 21–30
Parity 2.9 2 1–4
Gestational age (weeks) 22 23 12–28
Hemoglobin (g/dl) 9.6 9.7 8.8–10.6
Birth weight of the offspring (g) 3017 3000 2750–3350
doi:10.1371/journal.pone.0098577.t001
Adhesion Phenotype of Isolates from Pregnant Women
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isolates from both primi- and multigravidae bound CD36 and
ICAM-1 to similar levels (Table 5). Likewise, when the threshold
of significant binding was applied, the analysis revealed a trend of
parasites from primigravidae to adhere more frequently
(OR=3.2) to CSPG than those from multigravidae, although
not strictly significant (P= 0.11), possibly due to a lack of power
associated to our limited sample size. Although the affinity for
CD36 was more advantageous among isolates from multigravidae
with an unfavorable linear coefficient of -52.3 among isolates from
primigravidae (Figure 2B), this relationship was not observed in
our model of logistic regression analysis (OR=0.64, P= 0.6)
(Figure 2B). Regarding adhesion to ICAM-1, the logistic
regression model failed to converge, due to numerical trouble.
To investigate whether gestational age is associated with a
particular binding phenotype of isolates, a cut-off was made at 16
weeks of gestational age to define early (,16 weeks) and late
pregnancy (.16 weeks). For ICAM-1 receptor, the mixed models
failed to converge. Isolates from late pregnancy bound CSPG to a
higher level than those from early pregnancy (P= 0.03, Table 4).
The opposite was observed with CD36, with a lower binding level
of late pregnancy parasites (P= 0.02). This lower ability of isolates
from late pregnancy to bind CD36 was confirmed also by logistic
regression analysis (OR=0.14; P= 0.01). No association was
observed between parasite density and binding phenotype of
the isolates. In addition, when analysis was done according to the
pregnancy outcome, such as the birth weight of the baby and the
level of maternal hemoglobin, no relationship was observed with a
particular adhesion pattern of IE.
Discussion
The ability of P. falciparum IE to bind to CSA is the key factor
that mediates placental sequestration and consequently the
pathogenesis of malaria during pregnancy. Several studies have
described the particular adhesion phenotype that characterizes
parasites collected from women during pregnancy [3,23,25,36],
demonstrating evidence of a distinct binding ability to CSA shared
by such isolates. Most of these studies have focused on isolates
collected in late pregnancy [23,25,39], and observations have
greatly helped formulate the hypothesis that the parasite ligand
mediating adhesion to CSA would represent the main target for
potential vaccine development against PAM. However, few studies
have investigated the binding phenotypes of parasites infecting
pregnant women early in pregnancy, their dynamics throughout
pregnancy in relation to VAR2CSA expression, and whether
pregnancy-related factors such as parity and gestational age can
influence these phenotypes.
Recently, we have demonstrated that infection by CSA-binding
isolates occurs in the first trimester of pregnancy [36]. Not all
Figure 2. Adhesion profile of isolates from pregnant women. The binding phenotype of isolates was assessed on CSPG, CD36 and ICAM-1
receptors and presented as proportion of ‘‘positive’’ adhesion to each receptor, defined at binding $35 IE/mm2 (A) – The binding profile of all tested
isolates and (B) The segregation of the isolates binding profile according to the parity of women.
doi:10.1371/journal.pone.0098577.g002
Table 3. Predominant var genes transcripts in PAM isolates adhering to CSA and CD36, P,0.0001*.
var gene groups var ABC var1 var2csa
CSA-adhering isolatesa (n = 32) 0 12.5 87.5
CD36-adhering isolatesa (n = 13) 23 46 31
*Fisher Exact test.
aadhesion defined as binding $35 IE/mm2.
doi:10.1371/journal.pone.0098577.t003
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isolates collected at this stage of pregnancy bound to CSA. In this
study, we collected and analyzed the parasites from peripheral
blood of pregnant women at different times of pregnancy. In
addition to CSA, we have now assessed which of the other
receptors (CD36 and ICAM-1) are most commonly preferred by
isolates collected throughout pregnancy and investigated whether
infection by parasites with an adhesion pattern to these receptors
in a particular timing of pregnancy could be associated with poor
outcome. Variability in the binding phenotype of isolates was
observed throughout pregnancy. Our data highlights the coexis-
tence of parasites with several binding phenotypes in early
pregnancy isolates. But, this diversity gradually tightens with
gestational age in favor of the CSA binding phenotype. This
finding points out the high risk of women infection by parasites
with CSA-binding phenotype late in pregnancy, suggesting that
isolates with adhesion pattern to other receptor are less involved in
the pathogenesis of PAM requiring placental tropism.
However, adhesion to CSA was the most prevalent phenotype
displayed by peripheral isolates from pregnant women compared
to binding to either CD36 or ICAM-1. Generally, these isolates
bound to CSA at higher levels compared to CD36 and ICAM-1.
Although the placental tropism of CSA-binding parasites might
explain this adhesion preference of the isolates, a possible role of
the pre-existing immunity in these women, against CD36- and
ICAM-1-binding parasites should be considered. This pre-existing
immunity acquired from childhood mainly against CD36- and
ICAM-1-binding parasites could be an important filter. As already
described [20,25,39], interactions with ICAM-1 were observed
with few isolates from pregnant women, while adhesion to CD36
was more frequently observed among isolates from multigravidae
(28%) than those from primigravidae (20%). These observations
clearly indicate that infections with parasites not adhering to CSA
also occur during the pregnancy. Although the importance of
these infections in the outcome of pregnancy is unknown, their
characterization remains an open issue in the context of pregnancy
success in malaria-endemic regions. Such infections are dependent
on gestational age, occurring earlier in pregnancy and gradually
decreasing with increasing gestational age. It is likely that the
generalized immuno-modulation that occurs during pregnancy
favors infections with P. falciparum regardless of the binding
phenotype in primigravid women. The restriction of this
phenotype to parasites with a preference for CSA occurs gradually
as the placenta grows and becomes increasingly irrigated. It is
quite plausible that interventions like IPTp also promote this
phenotypic refining by increasing the fitness of placental parasites
that will be more preferably selected in subsequent infections. On
the other hand, non-CSA binding phenotypes seem to be more
common in multigravidae, in whom immunity against CSA-
binding parasites is well described [40,41]. The re-emergence of
infections with non-CSA binding parasites suggests better control
of CSA-binding phenotypes via acquired immunity, thereby
restoring the diversity of binding properties observed in non-
pregnant individual. However, we did not observe a significant
association between a particular adhesion phenotype of isolates
and outcomes such as the maternal hemoglobin and birth weight
of babies, probably due to the fact that all the infected pregnant
women were systematically treated in this study.
Many studies have demonstrated the high susceptibility of
women to PAM during the first pregnancy due to the lack of the
protective immunity that is acquired following successive preg-
nancies [1,15,42]. In line with these reports, our data emphasize
the high vulnerability of primigravid women to infection by
parasites with a CSA-binding phenotype. This increased vulner-
ability suggests that these parasites that strongly adhere to CSA are
those that cause the worst pregnancy outcomes, as supported by
their high frequency in primigravidae, who are the most at risk of
malaria consequences during pregnancy [1,3,42].
On the other hand, measurement of the transcription level of
var2csa compared to other var genes were performed, and its
expression as a protein on the surface of IE was assessed by use of
specific anti-VAR2CSA antibodies. High transcription level of
var2csa was observed among PAM-isolates, in agreement with prior
reports that have identified this gene as being specifically highly
transcribed in isolates from pregnant women. Although var2csa
transcripts were detected in most isolates, infections with parasites
that dominantly transcribed other var genes were observed. Most
of these isolates preferentially bound to CD36 and/or ICAM-1.
The binding preference to CSA was exclusively observed among
isolates in which the transcription of var2csa was clearly dominant
over that of the other var genes [43,44]. Co-expression of multiple
var genes, due to clonal phenotypic variation of parasites and to the
multiplicity of infections, might explain the fact that some isolates
were able to bind to more than one receptor.
The positive association between the surface expression of
VAR2CSA and ability of IE to bind CSA supports previous
reports indicating VAR2CSA is the main protein involved in this
interaction. However, some few isolates did not bind CSA whilst
simultaneously exhibiting both a marked predominant transcrip-
tion of var2csa and a specific labeling of VAR2CSA on the IE
surface. A plausible explanation might be that the immobilized
receptor binding-assay does not fully reproduce the physiological
conditions mediating in vivo interactions, due to differences in
protein conformation and localization. However, previous studies
have demonstrated a variable ability of placental isolates to bind
CSA [3,20]. Further investigations using cell-based methods under
flow conditions are needed to better characterize these low CSA-
binding isolates, and to assess whether other factors or proteins are
involved in the CSA-binding process. Conversely, in some isolates
that showed binding to CSA, predominant transcription of other
var genes instead of var2csa was noted. The polyclonal nature of
Table 4. CSA-binding isolates and VAR2CSA surface expression in PAM isolates predominantly transcribing var2csa and non-
var2csa genes.
Dominant var gene
transcribed
CSA-adhering isolatesa
(n =32)
VAR2CSA surface
detection**
Non or weakly CSA-adhering
isolatesb (n =22)
VAR2CSA surface
detection**
var2csa 28 28 10 10
non-var2csa 4 4 12 1
**Significant surface labeling by VAR2CSA antibodies with MFI ratio .1.2.
aadhesion defined as binding $35 IE/mm2.
bbinding level ,35 IE/mm2.
doi:10.1371/journal.pone.0098577.t004
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pregnant women infections may partially explain this observation.
It is also possible that the dominant transcribed var genes in these
isolates might encode for particular adhesion phenotype which was
not explored in this study. However, a possible role of other non-
VAR2CSA parasite proteins expressed on the surface of IE in the
interaction with the CSA is not to be excluded. Further studies are
still needed to make this clarification.
In summary, the data presented here are of capital importance
in the context of VAR2CSA-based vaccine development. Actually
the expression of VAR2CSA appears as the major feature shared
by the P. falciparum parasites infecting pregnant women. These
data suggest a major interest in VAR2CSA variants that express a
strong adhesion ability to CSA as a critical aspect to be considered
in the ongoing effort of vaccine development.
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